PCA-CGAN Ablation Experiment Results. by Chao Tang (10925)

“…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. After data augmentation, the ResNet model’s average F1 score improved significantly, with particularly outstanding performance on rare categories such as atrial premature beats, far surpassing traditional methods like SigCWGAN and TD-GAN. …”

Fig 1 - by Samuel Hylander (331771)

Fig 3 - by Samuel Hylander (331771)

Fig 4 - by Samuel Hylander (331771)

Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L^-1... by Sandra Thalerová (11434762)

Comparison of the mean number of unique diagnoses per hospital admission, between 2000 and 2023, stratified by chapters of ICD-10. The table shows absolute and relative changes in... by Stuart A. Bowyer (21253319)

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. by Hala Tamim El Jarkass (16625309)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: by Vidya G. Bettada (22208808)

“…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…”

Data Sheet 1_Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.docx by Yulin Zhang (510822)

“…Knockdown of HNRNPC in the HNSCC cell lines HSC-3 and CAL-27 resulted in a significant decrease in proliferation, invasion, and malignant transformation abilities. …”

Seasonal spatial-temporal trend of NDVI of burned forested areas in Africa (2001–2020). by Oswaldo Maillard (20660661)

“…<p>Areas with increasing (green) or decreasing (red) vegetation, based on the Mann-Kendall test and statistically significance values (<i>p</i> < 0.05) for DJF (December-February), MAM (March-May), JJA (June-August) and SON (September-November). …”